Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997

SEC filing history

Showing 551-575 of 936 matching filings.

Per page
25
Current page
23
4

FORM 4 SUBMISSION

Filing date
06 Apr 2016
Reporting date
04 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
07 Mar 2016
Reporting date
02 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-22873

CT ORDER filing

Filing date
01 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-51477

SC 13G/A

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-51477

ARCA SCHEDULE 13G/A 2-12-16

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-51477

SC 13G

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
12 Jan 2016
Reporting date
12 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-51477

SC 13G filing

Filing date
08 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-51477

SABBY 13G-A ABIO 1.06.16

Filing date
06 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-187508

EFFECT filing

Filing date
26 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Oct 2015
Reporting date
16 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-187508

POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-1

Filing date
16 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .